Lonza Group stock trades at CHF 565.60 as Goldman keeps Buy rating

Lonza Group (ISIN CH0013841017) was last quoted at CHF 565.60 on the SIX Swiss Exchange on October 2, 2026 at 5:33 p.m. CET, up 0.89 percent on the session. Markets Insider reported on October 1, 2026 that Goldman Sachs maintained a Buy rating and a CHF 680.00 price target. The modest daily gain leaves the stock below the latest analyst target range rather than establishing a fresh price breakout. Goldman keeps its CHF 680 target Goldman Sachs was not the only bullish view in the recent analyst record. Marketscreener lists a Buy consensus from 24 analysts, with an average target of CHF 688.17. That target lies 21.69 percent above the October 2 reference price of CHF 565.60, giving the consensus a measurable premium to the latest SIX quotation. Q2 revenue reaches CHF 3.37 billion EQS News said on September 30, 2026 that Lonza generated CHF 3.4 billion in sales and CHF 1.2 billion in CORE EBITDA during Half-Year 2026. The company also reported Q2 2026 revenue of CHF 3.37 billion and net profit of CHF 591 million, according to Markets Insider. The comparison with Q2 2025 is important for valuation: revenue increased from CHF 3.03 billion to CHF 3.37 billion, an 11.22 percent gain, while net profit rose from CHF 426 million to CHF 591 million, a 38.73 percent increase. The earnings profile therefore supplies a stronger operating case than the 0.89 percent session move alone. Stock remains 5.39 percent below high Lonza Group stock stood 5.39 percent below its 52-week high of CHF 597.80 and 24.42 percent above its 52-week low of CHF 454.60 on October 2, 2026. Daily trading ranged from CHF 554.40 to CHF 570.20, with volume of 89,718 shares. Lonza Group stock facts Company: Lonza Group AG Lonza Group AG ISIN: CH0013841017 CH0013841017 WKN: 928619 928619 Ticker: LONN LONN Trading venue: SIX Swiss Exchange SIX Swiss Exchange Price (as of October 2, 2026, 5:33 p.m. CET): CHF 565.60 CHF 565.60 52-week range: CHF 454.60-597.80 (as of October 2, 2026) CHF 454.60-597.80 (as of October 2, 2026) Sector / Industry: Chemistry and biotechnology Chemistry and biotechnology Index membership: SMI More news and analyses on Lonza Group stock